Insider Selling: Calumet (NASDAQ:CLMT) Director Sells 3,310 Shares of Stock

Calumet, Inc. (NASDAQ:CLMT) Director Daniel Sajkowski sold 3,310 shares of the firm’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $34.46, for a total transaction of $114,062.60. Following the completion of the transaction, the director owned 81,958 shares in the company, valued at approximately $2,824,272.68. The trade was a 3.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Calumet Stock Performance

Shares of NASDAQ CLMT traded up $0.47 during midday trading on Thursday, hitting $35.06. The company’s stock had a trading volume of 1,082,506 shares, compared to its average volume of 1,491,751. Calumet, Inc. has a 1-year low of $7.68 and a 1-year high of $36.94. The firm’s fifty day moving average price is $27.64 and its 200-day moving average price is $22.21. The firm has a market cap of $3.04 billion, a P/E ratio of -89.90 and a beta of 0.85.

Calumet (NASDAQ:CLMT) last released its quarterly earnings data on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share for the quarter, topping the consensus estimate of ($0.67) by $0.24. The business had revenue of $1.04 billion for the quarter, compared to analyst estimates of $1.04 billion. During the same quarter last year, the company earned ($0.47) EPS. Calumet’s revenue was up 9.4% compared to the same quarter last year. As a group, research analysts predict that Calumet, Inc. will post -3.02 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Wall Street Zen downgraded Calumet from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. UBS Group reaffirmed a “neutral” rating and issued a $26.00 target price on shares of Calumet in a research report on Friday, February 13th. TD Cowen raised their target price on Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a research note on Thursday, March 5th. HC Wainwright boosted their price target on shares of Calumet from $33.00 to $60.00 and gave the company a “buy” rating in a report on Monday. Finally, The Goldman Sachs Group upped their price target on shares of Calumet from $24.00 to $34.00 and gave the stock a “buy” rating in a research report on Thursday, March 12th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $30.17.

More Calumet News

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright boosted earnings estimates across 2026 and 2027, moved FY2027 from a negative to a $1.07 EPS forecast, kept a “Buy” rating and $60 price target — signaling meaningful analyst confidence in the company’s recovery and upside potential. Calumet (NASDAQ:CLMT) Stock Price Expected to Rise, HC Wainwright Analyst Says
• Positive Sentiment: Heavy volume and recent earnings‑estimate upgrades have produced strong short‑term momentum (recent one‑day surge noted by market coverage), which can attract additional buying interest from momentum and event‑driven traders. Calumet, Inc. (CLMT) Soars 12%: Is Further Upside Left in the Stock?
• Neutral Sentiment: Analysts and commentators are reassessing valuation after the recent run; a higher multiple may be justified if growth/earnings revisions hold, but elevated expectations raise execution risk. A Look At Calumet (CLMT) Valuation After Its Recent Share Price Surge
• Negative Sentiment: Operational risk: Calumet reported unplanned maintenance at its Shreveport facility late in Q1 after detection of organic chlorides in feedstock tanks. That could reduce near‑term throughput, raise maintenance costs and weigh on Q1/Q2 volumes until fully resolved. Calumet Announces First Quarter 2026 Operational Update

Hedge Funds Weigh In On Calumet

Several hedge funds and other institutional investors have recently made changes to their positions in CLMT. Two Seas Capital LP grew its holdings in Calumet by 56.9% in the 2nd quarter. Two Seas Capital LP now owns 4,497,609 shares of the oil and gas company’s stock worth $70,860,000 after buying an additional 1,631,098 shares in the last quarter. AYAL Capital Advisors Ltd acquired a new position in Calumet during the 2nd quarter worth $5,278,000. Mariner LLC boosted its position in Calumet by 959.6% during the 3rd quarter. Mariner LLC now owns 369,408 shares of the oil and gas company’s stock worth $6,742,000 after acquiring an additional 334,544 shares during the period. Marshall Wace LLP grew its stake in shares of Calumet by 35.8% in the third quarter. Marshall Wace LLP now owns 891,390 shares of the oil and gas company’s stock worth $16,268,000 after purchasing an additional 234,766 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in shares of Calumet by 128.3% in the fourth quarter. Goldman Sachs Group Inc. now owns 348,115 shares of the oil and gas company’s stock worth $6,917,000 after purchasing an additional 195,627 shares in the last quarter. 34.41% of the stock is currently owned by institutional investors and hedge funds.

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.